Human viral oncogenesis: A cancer hallmarks analysis

Cell Host and Microbe

Volumn 15, Issue 3, 2014, Pages 266-282

  Mesri, Enrique A ^a,b   Feitelson, Mark A ^c   Munger, Karl ^d  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c Temple University   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; BURKITT LYMPHOMA; CARCINOGENESIS; CARCINOGENICITY; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GENETIC VARIABILITY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; INFLAMMATION; KAPOSI SARCOMA; LIVER CELL CARCINOMA; MOLECULAR BIOLOGY; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; NONHUMAN; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; REVIEW; T CELL LEUKEMIA; VIRUS INFECTION; VIRUS ONCOGENE; VIRUS REPLICATION; WART VIRUS;

CARCINOGENESIS; HOST-PATHOGEN INTERACTIONS; HUMANS; NEOPLASMS; VIRUS DISEASES;

EID: 84896088630     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2014.02.011     Document Type: Review

References (134)

1. Aoki, Y., and Tosato, G. (2007). Interactions between HIV-1 Tat and KSHV. Curr. Top. Microbiol. Immunol. 312, 309-326. (Pubitemid 47400342)
2. Aoki, Y., Jaffe, E.S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P.S., and Tosato, G. (1999). Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93, 4034-4043. (Pubitemid 29279245)
3. Arvey, A., Tempera, I., Tsai, K., Chen, H.S., Tikhmyanova, N., Klichinsky, M., Leslie, C., and Lieberman, P.M. (2012). An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe 12, 233-245.
4. Arzumanyan, A., Friedman, T., Ng, I.O., Clayton, M.M., Lian, Z., and Feitelson, M.A. (2011). Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res. 71, 3701-3708.
5. Arzumanyan, A., Reis, H.M., and Feitelson, M.A. (2013). Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat. Rev. Cancer 13, 123-135.
6. Assrir, N., Soussan, P., Kremsdorf, D., and Rossignol, J.M. (2010). Role of the hepatitis B virus proteins in pro- and anti-apoptotic processes. Front Biosci (Landmark Ed) 15, 12-24.
7. Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E.G., Gutkind, J.S., Asch, A.S., Cesarman, E., Gershengorn, M.C., and Mesri, E.A. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391, 86-89. (Pubitemid 28079220)
8. Bais, C., Van Geelen, A., Eroles, P., Mutlu, A., Chiozzini, C., Dias, S., Silverstein, R.L., Rafii, S., and Mesri, E.A. (2003). Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell 3, 131-143. (Pubitemid 37443386)
9. Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., and Cogliano, V.; WHO International Agency for Research on Cancer Monograph Working Group (2009). A review of human carcinogens - Part B: biological agents. Lancet Oncol. 10, 321-322.
10. Boyle, P., and Levin, B. (2008). World Cancer Report 2008. (Lyon: International Agency for Research on Cancer and World Health Organization Press).
11. Brault, C., Levy, P.L., and Bartosch, B. (2013). Hepatitis C virus-induced mitochondrial dysfunctions. Viruses 5, 954-980.
12. Bréchot, C. (2004). Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127 (Suppl 1), S56-S61.
13. Brinkmann, M.M., Pietrek, M., Dittrich-Breiholz, O., Kracht, M., and Schulz, T.F. (2007). Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus. J. Virol. 81, 42-58. (Pubitemid 44975145)
14. Cadwell, K., and Coscoy, L. (2005). Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309, 127-130. (Pubitemid 40934990)
15. Cai, Q.L., Knight, J.S., Verma, S.C., Zald, P., and Robertson, E.S. (2006). EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog. 2, e116.
16. Casper, C. (2011). The increasing burden of HIV-associated malignancies in resource-limited regions. Annu. Rev. Med. 62, 157-170.
17. Cesarman, E., and Mesri, E.A. (2006). Pathogenesis of viral lymphomas. Cancer Treat. Res. 131, 49-88.
18. Cesarman, E., and Mesri, E.A. (2007). Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. Curr. Top. Microbiol. Immunol. 312, 263-287. (Pubitemid 47400340)
19. Chang, H.H., and Ganem, D. (2013). A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity. Cell Host Microbe 13, 429-440.
20. Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M., and Moore, P.S. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869.
21. Chen, W., Li, F., Mead, L., White, H., Walker, J., Ingram, D.A., and Roman, A. (2007). Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior. Virology 367, 168-174. (Pubitemid 47418936)
22. Cheng, F., Pekkonen, P., Laurinavicius, S., Sugiyama, N., Henderson, S., Günther, T., Rantanen, V., Kaivanto, E., Aavikko, M., Sarek, G., et al. (2011). KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. Cell Host Microbe 10, 577-590.
23. Ching, Y.P., Chan, S.F., Jeang, K.T., and Jin, D.Y. (2006). The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat. Cell Biol. 8, 717-724.
24. Choi, Y.B., and Nicholas, J. (2010). Bim nuclear translocation and inactivation by viral interferon regulatory factor. PLoS Pathog. 6, e1001031.
25. Coscoy, L. (2007). Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat. Rev. Immunol. 7, 391-401.
26. de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., and Plummer, M. (2012). Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 13, 607-615.
27. Delgado, T., Carroll, P.A., Punjabi, A.S., Margineantu, D., Hockenbery, D.M., and Lagunoff, M. (2010). Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc. Natl. Acad. Sci. USA 107, 10696-10701.
28. Delgado, T., Sanchez, E.L., Camarda, R., and Lagunoff, M. (2012). Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection. PLoS Pathog. 8, e1002866.
29. DiMaio, D., and Petti, L.M. (2013). The E5 proteins. Virology 445, 99-114.
30. Duffy, C.L., Phillips, S.L., and Klingelhutz, A.J. (2003). Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6. Virology 314, 196-205. (Pubitemid 37153310)
31. Dürst, M., Croce, C.M., Gissmann, L., Schwarz, E., and Huebner, K. (1987). Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc. Natl. Acad. Sci. USA 84, 1070-1074. (Pubitemid 17031570)
32. Ellis, M., Chew, Y.P., Fallis, L., Freddersdorf, S., Boshoff, C., Weiss, R.A., Lu, X., and Mittnacht, S. (1999). Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J. 18, 644-653. (Pubitemid 29057249)
33. Feitelson, M.A., and Lee, J. (2007). Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett. 252, 157-170. (Pubitemid 46809787)
34. Feitelson, M.A., Reis, H.M., Liu, J., Lian, Z., and Pan, J. (2005). Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis. Front. Biosci. 10, 1558-1572. (Pubitemid 40529020)
35. Friborg, J., Jr., Kong, W., Hottiger, M.O., and Nabel, G.J. (1999). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-894.
36. Fujimuro, M., Wu, F.Y., ApRhys, C., Kajumbula, H., Young, D.B., Hayward, G.S., and Hayward, S.D. (2003). A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9, 300-306. (Pubitemid 36362785)
37. Ganem, D. (2010). KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 120, 939-949.
38. George Paul, A., Sharma-Walia, N., Kerur, N., White, C., and Chandran, B. (2010). Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen. Cancer Res. 70, 3697-3708.
39. Goodwin, E.C., Yang, E., Lee, C.J., Lee, H.W., DiMaio, D., and Hwang, E.S. (2000). Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 97, 10978-10983.
40. Grassmann, R., Aboud, M., and Jeang, K.T. (2005). Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24, 5976-5985. (Pubitemid 43086115)
41. Gregory, S.M., Davis, B.K., West, J.A., Taxman, D.J., Matsuzawa, S., Reed, J.C., Ting, J.P., and Damania, B. (2011). Discovery of a viral NLR homolog that inhibits the inflammasome. Science 331, 330-334.
42. Grossmann, C., Podgrabinska, S., Skobe, M., and Ganem, D. (2006). Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J. Virol. 80, 7179-7185. (Pubitemid 44025214)
43. Guasparri, I., Keller, S.A., and Cesarman, E. (2004). KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199, 993-1003. (Pubitemid 38481090)
44. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70. (Pubitemid 30046295)
45. Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
46. Hellner, K., Mar, J., Fang, F., Quackenbush, J., and Münger, K. (2009). HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition. Virology 391, 57-63.
47. Höfelmayr, H., Strobl, L.J., Marschall, G., Bornkamm, G.W., and Zimber-Strobl, U. (2001). Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells. J. Virol. 75, 2033-2040. (Pubitemid 32147542)
48. Iwakiri, D., Zhou, L., Samanta, M., Matsumoto, M., Ebihara, T., Seya, T., Imai, S., Fujieda, M., Kawa, K., and Takada, K. (2009). Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J. Exp. Med. 206, 2091-2099.
49. Jensen, K.K., Manfra, D.J., Grisotto, M.G., Martin, A.P., Vassileva, G., Kelley, K., Schwartz, T.W., and Lira, S.A. (2005). The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J. Immunol. 174, 3686-3694. (Pubitemid 40354079)
50. Jeong, S.W., Jang, J.Y., and Chung, R.T. (2012). Hepatitis C virus and hepatocarcinogenesis. Clin Mol Hepatol 18, 347-356.
51. Jin, Y.M., Yun, C., Park, C., Wang, H.J., and Cho, H. (2001). Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases. J. Viral Hepat. 8, 322-330. (Pubitemid 34205885)
52. Kaiser, C., Laux, G., Eick, D., Jochner, N., Bornkamm, G.W., and Kempkes, B. (1999). The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J. Virol. 73, 4481-4484. (Pubitemid 29189900)
53. Karki, R., Lang, S.M., and Means, R.E. (2011). The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation. PLoS Pathog. 7, e1001331.
54. Keith, B., and Simon, M.C. (2007). Hypoxia-inducible factors, stem cells, and cancer. Cell 129, 465-472. (Pubitemid 46660978)
55. Kew, M.C. (2011). Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J. Gastroenterol. Hepatol. 26 (Suppl 1), 144-152.
56. Kirchmaier, A.L., and Sugden, B. (1997). Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J. Virol. 71, 1766-1775. (Pubitemid 27078552)
57. Knight, J.S., Sharma, N., and Robertson, E.S. (2005). Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc. Natl. Acad. Sci. USA 102, 18562-18566. (Pubitemid 43011265)
58. Kumthip, K., Chusri, P., Jilg, N., Zhao, L., Fusco, D.N., Zhao, H., Goto, K., Cheng, D., Schaefer, E.A., Zhang, L., et al. (2012). Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling. J. Virol. 86, 8581-8591.
59. Küppers, R. (2009). The biology of Hodgkin's lymphoma. Nat. Rev. Cancer 9, 15-27.
60. Kutok, J.L., and Wang, F. (2006). Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 1, 375-404.
61. Kwok, R.P., Laurance, M.E., Lundblad, J.R., Goldman, P.S., Shih, H., Connor, L.M., Marriott, S.J., and Goodman, R.H. (1996). Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380, 642-646. (Pubitemid 26119020)
62. Lan, K., Verma, S.C., Murakami, M., Bajaj, B., Kaul, R., and Robertson, E.S. (2007). Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc. Natl. Acad. Sci. USA 104, 16287-16292. (Pubitemid 350099398)
63. Langelier, M.F., and Pascal, J.M. (2013). PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis. Curr. Opin. Struct. Biol. 23, 134-143.
64. Leung, K., and Nabel, G.J. (1988). HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature 333, 776-778.
65. Ma, Q., Cavallin, L.E., Leung, H.J., Chiozzini, C., Goldschmidt-Clermont, P.J., and Mesri, E.A. (2013). A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis. Antioxid. Redox Signal. 18, 80-90.
66. Machida, K., Chen, C.L., Liu, J.C., Kashiwabara, C., Feldman, D., French, S.W., Sher, L., Hyeongnam, J.J., and Tsukamoto, H. (2012). Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus. J. Gastroenterol. Hepatol. 27 (Suppl 2), 19-22.
67. Martin-Vilchez, S., Lara-Pezzi, E., Trapero-Marugán, M., Moreno-Otero, R., and Sanz-Cameno, P. (2011). The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection. Rev. Med. Virol. http://dx.doi.org/10.1002/rmv.699.
68. Martinez-Pastor, B., Cosentino, C., and Mostoslavsky, R. (2013). A tale of metabolites: the cross-talk between chromatin and energy metabolism. Cancer Discov 3, 497-501.
69. Maruyama, M., Shibuya, H., Harada, H., Hatakeyama, M., Seiki, M., Fujita, T., Inoue, J., Yoshida, M., and Taniguchi, T. (1987). Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell 48, 343-350. (Pubitemid 18095353)
70. Matsuda, Y., and Ichida, T. (2009). Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis. Med. Mol. Morphol. 42, 138-142.
71. Matsuoka, M., and Jeang, K.T. (2007). Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7, 270-280. (Pubitemid 46480972)
72. McCormick, C., and Ganem, D. (2005). The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307, 739-741. (Pubitemid 40194646)
73. McFadden, K., and Luftig, M.A. (2013). Interplay between DNA tumor viruses and the host DNA damage response. Curr. Top. Microbiol. Immunol. 371, 229-257.
74. McLaughlin-Drubin, M.E., Meyers, J., and Munger, K. (2012). Cancer associated human papillomaviruses. Curr Opin Virol 2, 459-466.
75. Merchant, M., Caldwell, R.G., and Longnecker, R. (2000). The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J. Virol. 74, 9115-9124.
76. Mesri, E.A., Cesarman, E., and Boshoff, C. (2010). Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer 10, 707-719.
77. Montaner, S., Sodhi, A., Molinolo, A., Bugge, T.H., Sawai, E.T., He, Y., Li, Y., Ray, P.E., and Gutkind, J.S. (2003). Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3, 23-36. (Pubitemid 37443889)
78. Montaner, S., Sodhi, A., Ramsdell, A.K., Martin, D., Hu, J., Sawai, E.T., and Gutkind, J.S. (2006). The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res. 66, 168-174. (Pubitemid 43166022)
79. Moody, C.A., and Laimins, L.A. (2009). Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 5, e1000605.
80. Moody, C.A., and Laimins, L.A. (2010). Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 10, 550-560.
81. Moore, P.S., and Chang, Y. (2010). Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 10, 878-889.
82. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C., and Kieff, E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399.
83. Münger, K., Hayakawa, H., Nguyen, C.L., Melquiot, N.V., Duensing, A., and Duensing, S. (2006). Viral carcinogenesis and genomic instability. EXS, 179-199.
84. Mutlu, A.D., Cavallin, L.E., Vincent, L., Chiozzini, C., Eroles, P., Duran, E.M., Asgari, Z., Hooper, A.T., La Perle, K.M., Hilsher, C., et al. (2007). In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 11, 245-258. (Pubitemid 46357638)
85. Myoung, J., and Ganem, D. (2011). Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells. J. Clin. Invest. 121, 1130-1140.
86. Nakamura, H., Li, M., Zarycki, J., and Jung, J.U. (2001). Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J. Virol. 75, 7572-7582. (Pubitemid 32738015)
87. Nicholas, J., Ruvolo, V.R., Burns, W.H., Sandford, G., Wan, X., Ciufo, D., Hendrickson, S.B., Guo, H.G., Hayward, G.S., and Reitz, M.S. (1997). Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. Med. 3, 287-292. (Pubitemid 27112925)
88. Offermann, M.K. (2007). Kaposi sarcoma herpesvirus-encoded interferon regulator factors. Curr. Top. Microbiol. Immunol. 312, 185-209.
89. Portis, T., and Longnecker, R. (2004). Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 23, 8619-8628. (Pubitemid 39576469)
90. Raab-Traub, N. (2002). Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12, 431-441.
91. Radkov, S.A., Kellam, P., and Boshoff, C. (2000). The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6, 1121-1127.
92. Ray, R.B., Meyer, K., and Ray, R. (2000). Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 271, 197-204. (Pubitemid 30341528)
93. Rehermann, B. (2009). Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest. 119, 1745-1754.
94. Rochford, R., Cannon, M.J., and Moormann, A.M. (2005). Endemic Burkitt's lymphoma: a polymicrobial disease? Nat. Rev. Microbiol. 3, 182-187. (Pubitemid 40207598)
95. Roman, A., and Munger, K. (2013). The papillomavirus E7 proteins. Virology 445, 138-168.
96. Samols, M.A., Skalsky, R.L., Maldonado, A.M., Riva, A., Lopez, M.C., Baker, H.V., and Renne, R. (2007). Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog. 3, e65.
97. Sarek, G., Järviluoma, A., and Ojala, P.M. (2006). KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas. Blood 107, 725-732. (Pubitemid 43076399)
98. Sato, H., Oka, T., Shinnou, Y., Kondo, T., Washio, K., Takano, M., Takata, K., Morito, T., Huang, X., Tamura, M., et al. (2010). Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma. Am. J. Pathol. 176, 402-415.
99. Satou, Y., Yasunaga, J., Yoshida, M., and Matsuoka, M. (2006). HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. USA 103, 720-725. (Pubitemid 43153092)
100. Schiller, J.T., and Lowy, D.R. (2010). Vaccines to prevent infections by oncoviruses. Annu. Rev. Microbiol. 64, 23-41.
101. Shembade, N., Harhaj, N.S., Yamamoto, M., Akira, S., and Harhaj, E.W. (2007). The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation. J. Virol. 81, 13735-13742. (Pubitemid 350247866)
102. Shin, Y.C., Nakamura, H., Liang, X., Feng, P., Chang, H., Kowalik, T.F., and Jung, J.U. (2006). Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J. Virol. 80, 2257-2266. (Pubitemid 43271532)
103. Si, H., and Robertson, E.S. (2006). Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function. J. Virol. 80, 697-709. (Pubitemid 43062883)
104. Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E.A., and Gutkind, J.S. (2000). The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res. 60, 4873-4880.
105. Sodhi, A., Chaisuparat, R., Hu, J., Ramsdell, A.K., Manning, B.D., Sausville, E.A., Sawai, E.T., Molinolo, A., Gutkind, J.S., and Montaner, S. (2006). The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 10, 133-143. (Pubitemid 44175903)
106. Spangle, J.M., and Munger, K. (2013). The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species. PLoS Pathog. 9, e1003237.
107. Srisuttee, R., Koh, S.S., Kim, S.J., Malilas, W., Boonying, W., Cho, I.R., Jhun, B.H., Ito, M., Horio, Y., Seto, E., et al. (2012). Hepatitis B virus X (HBX) protein upregulates β-catenin in a human hepatic cell line by sequestering SIRT1 deacetylase. Oncol. Rep. 28, 276-282.
108. Stine, J.T., Wood, C., Hill, M., Epp, A., Raport, C.J., Schweickart, V.L., Endo, Y., Sasaki, T., Simmons, G., Boshoff, C., et al. (2000). KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 95, 1151-1157. (Pubitemid 30099820)
109. Swanton, C., Mann, D.J., Fleckenstein, B., Neipel, F., Peters, G., and Jones, N. (1997). Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390, 184-187. (Pubitemid 27507989)
110. Thompson, M.P., and Kurzrock, R. (2004). Epstein-Barr virus and cancer. Clin. Cancer Res. 10, 803-821. (Pubitemid 38198878)
111. Thorley-Lawson, D.A. (2001). Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1, 75-82.
112. Tian, Y., Yang, W., Song, J., Wu, Y., and Ni, B. (2013). Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol. Cell. Biol. 33, 2810-2816.
113. Tsimbouri, P., Drotar, M.E., Coy, J.L., and Wilson, J.B. (2002). bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes. Oncogene 21, 5182-5187.
114. Uchida, T., Kinoshita, T., Murate, T., Saito, H., and Hotta, T. (1998). CDKN2 (MTS1/p16INK4A) gene alterations in adult T-cell leukemia/lymphoma. Leuk. Lymphoma 29, 27-35. (Pubitemid 28236537)
115. Vande Pol, S.B., and Klingelhutz, A.J. (2013). Papillomavirus E6 oncoproteins. Virology 445, 115-137.
116. Vereide, D.T., Seto, E., Chiu, Y.F., Hayes, M., Tagawa, T., Grundhoff, A., Hammerschmidt, W., and Sugden, B. (2013). Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene. Published online March 18, 2013. http://dx.doi.org/10.1038/onc.2013.71.
117. Verma, S.C., Borah, S., and Robertson, E.S. (2004). Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J. Virol. 78, 10348-10359. (Pubitemid 39258360)
118. Vogelstein, B., and Kinzler, K.W. (1993). The multistep nature of cancer. Trends Genet. 9, 138-141. (Pubitemid 23098782)
119. Vrancken, K., Paeshuyse, J., and Liekens, S. (2012). Angiogenic activity of hepatitis B and C viruses. Antivir. Chem. Chemother. 22, 159-170.
120. Wang, W.L., London, W.T., Lega, L., and Feitelson, M.A. (1991). HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 14, 29-37.
121. Wang, L., Wakisaka, N., Tomlinson, C.C., DeWire, S.M., Krall, S., Pagano, J.S., and Damania, B. (2004). The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res. 64, 2774-2781. (Pubitemid 38500615)
122. Wang, L., Dittmer, D.P., Tomlinson, C.C., Fakhari, F.D., and Damania, B. (2006). Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res. 66, 3658-3666.
123. Weitzman, M.D., and Weitzman, J.B. (2014). What's the Damage? The Impact of Pathogens on Pathways that Maintain Host Genome Integrity. Cell Host Microbe 15, this issue, 283-294.
124. Xie, B., Xing, R., Chen, P., Gou, Y., Li, S., Xiao, J., and Dong, J. (2010). Downregulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference. J. Surg. Res. 162, 231-238.
125. Yip, W.K., Cheng, A.S., Zhu, R., Lung, R.W., Tsang, D.P., Lau, S.S., Chen, Y., Sung, J.G., Lai, P.B., Ng, E.K., et al. (2011). Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development. PLoS ONE 6, e22888.
126. Yoo, Y.G., Oh, S.H., Park, E.S., Cho, H., Lee, N., Park, H., Kim, D.K., Yu, D.Y., Seong, J.K., and Lee, M.O. (2003). Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway. J. Biol. Chem. 278, 39076-39084. (Pubitemid 37221811)
127. Yoshida, M. (2001). Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19, 475-496.
128. Young, L.S., and Rickinson, A.B. (2004). Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4, 757-768. (Pubitemid 39331148)
129. Zane, L., Yasunaga, J., Mitagami, Y., Yedavalli, V., Tang, S.W., Chen, C.Y., Ratner, L., Lu, X., and Jeang, K.T. (2012). Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis. Retrovirology 9, 114.
130. Zemel, R., Issachar, A., and Tur-Kaspa, R. (2011). The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma. Clin. Liver Dis. 15, 261-279, vii-x.
131. Zhao, P., Han, T., Guo, J.J., Zhu, S.L., Wang, J., Ao, F., Jing, M.Z., She, Y.L., Wu, Z.H., and Ye, L.B. (2012). HCV NS4B induces apoptosis through the mitochondrial death pathway. Virus Res. 169, 1-7.
132. Zhu, Y., Haecker, I., Yang, Y., Gao, S.J., and Renne, R. (2013). γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr Opin Virol 3, 266-275.
133. zur Hausen, H. (2009). The search for infectious causes of human cancers: where and why (Nobel lecture). Angew. Chem. Int. Ed. Engl. 48, 5798-5808.
134. Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., Eigenbrodt, E., and Jansen-Dürr, P. (1999). Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 96, 1291-1296. (Pubitemid 29098444)